Cerezyme (Imiglucerase) Drug Information: Uses, Side Effects, Drug ...
Learn about the prescription medication Cerezyme (Imiglucerase), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling.
Cerezyme (Imiglucerase) - updated on RxList
Cerezyme (Imiglucerase) drug description - FDA approved labeling for prescription drugs and medications at RxList.
Eight-Year Clinical Outcomes of Long-Term Enzyme Replacement ...
The goal was to analyze the clinical responses to enzyme replacement therapy with alglucerase or imiglucerase in a large international cohort of children with Gaucher disease type 1. METHODS. Anonymized data from 884 children in the ...
imiglucerase and its use for the treatment of gaucher's disease
expert opinion in pharmacotherapy.
Enzyme replacement therapy normalizes growth in pediatric Gaucher ...
NEW YORK (Reuters Health) - Long-term, continuous enzyme replacement therapy (ERT) with alglucerase or imiglucerase in children with Gaucher disease type 1 normalizes linear growth, enhances bone mineralization, and reduces liver and ...
First Patient Enrolled In Open-Label, Switchover Trial Of PrGCD ...
In the trial, patients with stable disease will be switched from intravenous imiglucerase treatment every two weeks to intravenous infusions of prGCD every two weeks for a nine-month period. The prGCD dose administered to each patient ...
cerezyme
about 15% of patients treated with cerezyme build up antibodies to imiglucerase. about 46% of patients with detectable antibodies hold experient an allergic reaction. emergency medical attention may be requisite if an hypersensitised ...
